Docket Number:10A-960105
Inventor:Han-Chung Wu, Chin-Tarng Lin, Tong-Young Lee, Szu-Yao Kuo
IP Status:US pending, TW I 365748
Abstract:
Antiangiogenic therapies for the treatment of cancers have the promise of high efficacy and low toxicity. A peptide marker was identified and characterized to home specifically to tumor blood vessels. It recognizes the neovasculature in tumors but not in normal blood vessels in SCID mice bearing human tumors. This peptide also binds stimulated HUVECs and blood vessels of human lung cancer biopsy specimens. The targeting peptide is a good candidate for targeted drug delivery to solid tumors and may prove useful for translational applications targeting tumor vasculature.
Fields of Application:
Adjuvant therapy of solid tumors
Anti-angiogenesis targeting therapy and diagnosis of solid tumors
Advantages when compared to the existing technologies:
Conventional chemotherapeutic agents react not only with tumor cells but also normal cells. This tumor-homing peptide provides an effective solution to this problem by specifically targeting tumor vessels. Several types of solid tumors can be treated by this targeting peptide conjugated with cancer chemotherapeutics.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
